Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1304381C reveals a zinc-catalyzed aqueous synthesis for 1,2,3,4-tetrazoles, offering high purity and cost reduction in pharmaceutical manufacturing.
Novel catalytic method for N-cyanoethylaniline reduces by-products and enables mother liquor recycling, offering significant cost and environmental advantages for dye manufacturing.
Patent CN107141248A enables visible light synthesis of 3-sulfonyl spirotrienones. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113264870A reveals a safer, cost-effective route for Apixaban intermediate APM07 using phase transfer catalysis, eliminating dangerous reagents for scalable manufacturing.
Patent CN107417573A reveals metal amide catalysis for carbamate. Offers high purity, atmospheric pressure, and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1224697C reveals a novel microbial process for high-purity aminoalcohols, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN111393480A reveals a stable bisphosphine carborane gold complex enabling mild, high-yield thiazole synthesis. Ideal for cost-effective pharmaceutical intermediate manufacturing.
Patent CN110862401B details a green one-pot synthesis for spiro indole derivatives using recyclable basic ionic liquids, offering significant cost and purity advantages for pharmaceutical intermediates.
Patent CN102216243A details a continuous copper-catalyzed cyclopropanation method, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for high-purity intermediates.
Patent CN113019449A details a green catalytic route for aromatic azoxy compounds using recyclable polyoxometallates, offering significant cost reduction and supply chain reliability for fine chemical intermediates.
High-purity chiral ligands and metal complexes for asymmetric synthesis. Efficient routes for pharmaceutical intermediates with superior enantioselectivity.
Patent CN104894148A details a high-efficiency omega-transaminase mutant for chiral amine synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN107686852B reveals a novel omega-transaminase route for moxifloxacin intermediates, offering high ee values and streamlined manufacturing for reliable pharmaceutical intermediate suppliers.
Novel Na/K alloy catalyzed synthesis ensures high yield and purity. Cost-effective solution for pharmaceutical intermediates and transition metal catalyst production.
Patent CN1761642A details an efficient asymmetric hydrogenation process for chiral beta-amino acids, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN111875510B reveals a novel continuous synthesis route for aminoacetaldehyde dimethyl acetal, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel quinine-catalyzed synthesis delivers high enantioselectivity and yield for pharmaceutical intermediates ensuring supply chain stability and cost efficiency.
Patent CN115557912A details a Pd/Cu catalyzed route for 2-aryl benzoxazoles. Offers high yield, green solvent, and scalable API intermediate manufacturing.
Advanced asymmetric oxidation process for high-purity Esomeprazole Sodium. Reduces impurities and enhances supply chain stability for global pharmaceutical manufacturers.
Discover the novel Pd/Cu-catalyzed synthesis of 2-keto aryl benzoxazoles from aryl carboxylic acids. A green, high-yield route for pharmaceutical intermediates offering significant cost advantages.